The CHOICE Act creates a new type of employer-funded health benefit called a "CHOICE arrangement," allowing small employers to reimburse employees for individual health insurance costs. It directly affects small businesses (not large employers under ACA rules) and their employees who choose individual marketplace coverage or specific government health programs. Key provisions include employer tax credits ($100/month for the first year, $50/month for the second year per employee), strict rules to prevent discrimination in plan access, and requirements for employees to maintain qualifying health coverage. The law takes effect for plan years beginning after December 31, 2025, providing a new option for small employers to offer health benefits without traditional group plans.
This bill expands tax-advantaged health accounts to cover medical expenses for parents. It modifies federal tax rules for Health Savings Accounts (HSAs), Flexible Spending Accounts (FSAs), and Archer MSAs, allowing adult children to use these accounts to pay for their parents' medical care without triggering tax penalties. Specifically, it adds parents to the list of eligible family members under existing IRS definitions. The changes apply to expenses incurred after December 31, 2025, directly benefiting caregivers who pay for their aging parents' healthcare costs.
This bill changes how the government calculates health insurance tax credits under the Affordable Care Act. It allows households with Medicare coverage to subtract Medicare premiums paid by family members (including Parts A, B, C, D, and supplemental policies) from the tax credit amount they receive. This affects people who qualify for premium tax credits and have household members enrolled in Medicare. The adjustment reduces the credit amount but cannot make it negative, and applies to coverage months starting after December 2025.
This bill establishes a federal working group under the Department of Health and Human Services to standardize how loneliness (a subjective feeling) and isolation (an objective lack of social contact) are measured across government and healthcare. The Working Group, composed of HHS agencies and state representatives from areas with high/low mental health practitioner shortages, will develop consistent metrics and definitions for research, public health initiatives, and healthcare tools. It requires the group to submit a report to Congress within one year of enactment, detailing recommendations for unified measurement standards. The effort is limited to improving data collection methods and expires by December 31, 2027.
The HCBS Relief Act of 2025 increases federal funding for Medicaid home and community-based services (HCBS) by 10 percentage points (capped at 95%) for participating states during fiscal years 2026-2027. It directly affects states that submit approved applications, Medicaid beneficiaries receiving HCBS, and home health workers by requiring states to use funds to raise wages/benefits for HCBS workers, reduce waiting lists, support family caregivers, and improve service quality. Key provisions mandate that states detail specific activities (like wage increases, paid leave, and equipment purchases) in applications, ensure funds supplement rather than replace state spending, and report on outcomes by 2029. The bill aims to strengthen HCBS access and workforce stability without changing Medicaid eligibility rules.
This bill (S 540) is procedural and adds a new "Continuity of care" provision to the Veterans Community Care Program under Section 1703(d)(2) of Title 38, U.S. Code. It does not describe specific policy changes or mechanisms, as the bill text only specifies the addition of the new subsection without detailing its content. The bill directly affects veterans enrolled in the Community Care Program by requiring consideration of continuity of care, though the exact requirements are not defined in the provided text. As a procedural amendment, it serves as a framework for future implementation rather than enacting immediate changes. Without additional bill text explaining the new provision's requirements, no concrete policy details can be summarized.
This bill requires Medicare to cover genetic counseling services provided by licensed or certified genetic counselors starting January 2027. It defines covered services and sets payment at 80% of the lower of the actual charge or 85% of the physician fee schedule. Medicare beneficiaries seeking genetic counseling and genetic counselors practicing in licensed or certified states will directly benefit from this expanded coverage. The bill also prohibits balance billing for these services and updates Medicare rules to clarify that physicians may still bill for genetic counseling if covered under existing rules.
The Disaster Relief Medicaid Act creates a new Medicaid program for survivors of major disasters declared after January 1, 2027. It provides simplified eligibility during a two-year relief coverage period (starting when the disaster is declared), allowing people in affected areas to access medical assistance without meeting standard income requirements. The law includes provisions for continuous eligibility, mental health services, home and community-based care, and 100% federal funding for these services. States must provide streamlined applications and issue special Medicaid cards valid for the entire relief period. It also includes specific protections for children born to survivors and pregnant individuals during the disaster period.
This bill requires most private health insurance plans to cover diagnostic and supplemental breast exams with no out-of-pocket costs (like deductibles or copays) for enrolled patients. It specifically covers exams used to evaluate abnormalities found in screenings (diagnostic) or for high-risk screening without abnormalities (supplemental), based on medical guidelines. Plans can still require prior authorization for these exams, and state laws offering stronger protections remain in effect. The rule takes effect for plan years starting January 1, 2026.
The Drug Shortage Prevention Act of 2025 requires manufacturers of critical drugs - such as life-saving medications for emergencies, surgery, or serious conditions - to notify the federal government about potential supply disruptions. Manufacturers must report planned production halts at least six months in advance or sudden issues like demand spikes within 10 business days, including reasons and expected duration. The bill also mandates twice-yearly reports on drug supply chains, detailing active ingredient sources and suppliers. This aims to improve transparency and prevent shortages affecting patient access to essential medications.